The low-dose ferroptosis inducer, IKE, when combined with the anti-TNF antagonist etanercept, was able to trigger fibroblast ferroptosis and lead to reduced cartilage and bone damage in the CIA experimental arthritis model. This evidence concerns the gene TNF and arthritic joint disease.